search
Back to results

An Intervention to Improve Prolapse Using Femmeze® (v1) (Femmeze®)

Primary Purpose

Rectocele, Pelvic Organ Prolapse

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Femmeze®
Sponsored by
Royal Cornwall Hospitals Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Rectocele focused on measuring splinting

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Adult women (over 18 years of age) with symptoms of obstructive defaecation
  • Not undergone posterior vaginal compartment prolapse surgery

Exclusion Criteria:

  • Cognitive impairment
  • Hand disability
  • Refuse to give informed consent
  • Pregnancy
  • Less than 12 weeks post-partum
  • Neurological disease

Sites / Locations

  • RoyalCornwallHT

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

Femmeze®

Arm Description

Femmeze® will be used by women in the intervention group for 8 weeks These women will be measuring against their usual care in a linear design; measurement will include validated questionnaires

Outcomes

Primary Outcome Measures

Quality of life instrument (ICIQ-Vaginal Symptoms)
http://www.iciq.net/ICIQ-VS.html

Secondary Outcome Measures

Device feedback questionnaire
evaluating the device from the participants perspective

Full Information

First Posted
October 15, 2014
Last Updated
March 27, 2019
Sponsor
Royal Cornwall Hospitals Trust
Collaborators
Peninsula Health
search

1. Study Identification

Unique Protocol Identification Number
NCT02280382
Brief Title
An Intervention to Improve Prolapse Using Femmeze® (v1)
Acronym
Femmeze®
Official Title
An Intervention to Improve the Management of Posterior Vaginal Compartment Prolapse Using Femmeze®: a Feasibility Study
Study Type
Interventional

2. Study Status

Record Verification Date
March 2019
Overall Recruitment Status
Completed
Study Start Date
October 2015 (Actual)
Primary Completion Date
December 2018 (Actual)
Study Completion Date
March 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Royal Cornwall Hospitals Trust
Collaborators
Peninsula Health

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The main purpose of the feasibility study is to identify the patient experience of Femmeze® which is a device aimed at improving posterior vaginal compartment prolapse (rectocele) for women with obstructive defaecation. The investigators want to investigate implementation and preliminary effectiveness of the device. The method of investigation will be a pre-post intervention design, which involves asking 30 women to use Femmeze® over a period of 8 weeks. This is an academic study on a labelled indication (http://www.nres.nhs.uk/search/?q=medical+devices).
Detailed Description
Aim Evaluate the feasibility of the Femmeze® device to improve management of posterior vaginal compartment prolapse addressing implementation of the intervention and preliminary effectiveness. Objectives demonstrate effectiveness of the device (comfort, ease of use, empty the rectum of stool more easily than their current approach and quality of life) identify which stage of prolapse the device would be most suitable identify any changes to the device or instructions for use (needs adjustment to its design in terms of length/width) The study will use a pre-post intervention design with the aim of evaluating the feasibility of the intervention (using the device); and identifying any implementation issues and preliminary effectiveness. The participants will be followed prospectively to compare the device against their own usual care. Usual care in this context will be using their fingers to help empty their rectum of stool. Participants will be invited to complete a semi-structured interview to understand their lived experience. A Patient and Public Involvement Group has contributed to improving the study methods.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Rectocele, Pelvic Organ Prolapse
Keywords
splinting

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
36 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Femmeze®
Arm Type
Other
Arm Description
Femmeze® will be used by women in the intervention group for 8 weeks These women will be measuring against their usual care in a linear design; measurement will include validated questionnaires
Intervention Type
Device
Intervention Name(s)
Femmeze®
Other Intervention Name(s)
5060228630194
Intervention Description
Femmeze will be used by women in the intervention group for 8 weeks These women will be measuring against their usual care in a linear design; measurement will include validated questionnaires
Primary Outcome Measure Information:
Title
Quality of life instrument (ICIQ-Vaginal Symptoms)
Description
http://www.iciq.net/ICIQ-VS.html
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Device feedback questionnaire
Description
evaluating the device from the participants perspective
Time Frame
12 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Adult women (over 18 years of age) with symptoms of obstructive defaecation Not undergone posterior vaginal compartment prolapse surgery Exclusion Criteria: Cognitive impairment Hand disability Refuse to give informed consent Pregnancy Less than 12 weeks post-partum Neurological disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sharon Eustice, BSc; MSc
Organizational Affiliation
RCHT
Official's Role
Principal Investigator
Facility Information:
Facility Name
RoyalCornwallHT
City
Truro
ZIP/Postal Code
TR1 3JL
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
Yes

Learn more about this trial

An Intervention to Improve Prolapse Using Femmeze® (v1)

We'll reach out to this number within 24 hrs